Tipranavir May Be Helpful for Multidrug-Resistant HIV-1 Infection
15th Nov 2006, 00:19 GMT
In 2 open-label trials, ritonavir-boosted tipranavir had greater antiviral activity at week 24 than did investigator-selected, ritonavir-boosted protease inhibitors in treatment-experienced patients. Medscape Medical News Laurie Barclay
Tipranavir May Be Helpful for Multidrug-Resistant HIV-1 Infection related news:
- Volume 194, number 12: Immune-Based Therapy for HIV Infection: Are Acute and Chronic HIV Infection Different Diseases? — J Infect Dis Latest Issue
- HIV/AIDS linked to extensively drug resistant TB — EurekAlert! - Breaking News
- Volume 194, number 12: Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV-1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138 — J Infect Dis Latest Issue
- Adolescent arrest history influences risk of acquiring HIV — EurekAlert! - Medicine and Health
- Progress Made In HIV Vaccine Development — ScienceDaily Headlines: Health & Medicine
- Antibodies destroy HIV-infected cells (Reuters) — Yahoo! Health: Health News
- Antibodies destroy HIV-infected cells — Reuters: Health
- Nigeria: AMAC First Lady Runs Radio Programme on Aids — AllAfrica News: HIV-Aids and STDs
- Volume 194, number 12: Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV-1 Vaccine among Injection Drug Users in Bangkok, Thailand — J Infect Dis Latest Issue
- Wild gorillas carriers of a SIV virus close to the AIDS virus — EurekAlert! - Breaking News